Notice of GM and proposed delisting from the AQSE

Flex Labs Inc.

08 August 2024

 

8 August 2024

Flex Labs Inc

("Flex" or the "Company")

Notice of general meeting and proposed delisting from the AQSE Growth Market

Flex Labs Inc (AQSE: FLEX) announces that a resolution to propose the cancellation of admission of the Company's common shares ("Common Shares") from the AQUIS Stock Exchange Growth Market ("AQSE" and the "Withdrawal") will be proposed at the Company's general meeting to be held at Suite 700 - 401 West Georgia Street, Vancouver, BC V6C 5A1, on Friday, 30 August 2024, at 10:00 a.m. (Pacific Standard Time).

The Company is in the business of developing and commercializing advanced artificial intelligence middleware products, to be primarily offered to business customers through a "software as a service" business model.  Since its admission for trading on the Exchange on 15 December 2023, trading of its Common Shares on AQSE has been in low volumes. In meeting with its investors and potential investors, and in considering the general investment opportunities in the United Kingdom, the directors of the Company ("Directors") have considered it to be in the best interests of the Company to pursue a listing in Canada.  Continued listing on AQSE would be a cost burden to the Company at this stage, and the ongoing costs of listing on AQSE may prove to be a potential impediment to the pursuit of listings in Canada from a cost perspective.

Therefore, the Directors have concluded that it is in the interest of shareholders to withdraw from AQSE as they do not consider that any potential benefits to the Company or Shareholders from retaining the AQSE admission are sufficient to justify the associated costs.

Subject to the Withdrawal resolution being passed, trading in the Company's Shares will cease at 7:00 a.m., UK time, on 6 September 2024.

A circular, including the Notice of General Meeting and containing further information relating to the proposed Withdrawal, will be posted to registered Shareholders and will be made available to Shareholders on the Company's website at www.flexlabs.ai. 

 The directors of Flex accept responsibility for this announcement.

For further information please contact:

Flex Labs Inc
Michael Edwards	Via First Sentinel
First Sentinel (Corporate Adviser)
Brian Stockbridge	[e-mail]   [phone]

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

END